1. Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107843. doi:10.1016/j.diabres.2019.107843
2. Gulshan V, Peng L, Coram M, et al. Development and validation of a deep learning algorithm for detection of diabetic retinopathy in retinal fundus photographs. JAMA. 2016;316(22):2402-2410. doi:10.1001/jama.2016.17216
3. Huang XM, Yang BF, Zheng WL, et al. Cost-effectiveness of Artificial Intelligence screening for diabetic retinopathy in rural China. BMC Health Serv Res. 2022;22(1):260. doi:10.1186/s12913-022-07655-6
4. Peng Y, Dharssi S, Chen Q, et al. DeepSeeNet: A deep learning model for automated classification of patient-based age-related macular degeneration severity from color fundus photographs. Ophthalmology. 2019;126(4):565-575. doi:10.1016/j.ophtha.2018.11.015
5. Li Z, Wang L, Wu X, et al. Artificial Intelligence in ophthalmology: the path to the real-world clinic. Cell Rep Med. 2023;4(7):101095. doi:10.1016/j.xcrm.2023.101095
6. Ting DSW, Cheung CY, Lim G, et al. Development and validation of a deep learning system for diabetic retinopathy and related eye diseases using retinal images from multiethnic populations with diabetes. JAMA. 2017;318(22):2211-2223. doi:10.1001/jama.2017.18152
7. Wong DCS, Kiew G, Jeon S, Ting D. Singapore eye lesions analyzer (SELENA): the deep learning system for retinal diseases. In: Grzybowski A, editor. Artificial Intelligence in Ophthalmology. Cham: Springer; 2021:177-185. doi:10.1007/978-3-030-78601-4_13
8. Xie Y, Nguyen QD, Hamzah H, et al. Artificial Intelligence for teleophthalmology-based diabetic retinopathy screening in a national programme: an economic analysis modelling study. Lancet Digit Health. 2020;2(5):240-249. doi:10.1016/S2589-7500(20)30060-1
9. Dismuke C. Progress in examining cost-effectiveness of AI in diabetic retinopathy screening. Lancet Digit Health. 2020;2(5):e212-e213. doi:10.1016/S2589-7500(20)30077-7
10. Leavitt JA, Larson TA, Hodge DO, Gullerud RE. The incidence of central retinal artery occlusion in Olmsted County, Minnesota. Am J Ophthalmol. 2011;152(5):820-823. doi:10.1016/j.ajo.2011.05.005
11. Song P, Xu Y, Zha M, Zhang Y, Rudan I. Global epidemiology of retinal vein occlusion: a systematic review and meta-analysis of prevalence, incidence, and risk factors. J Glob Health. 2019;9(1):010427. doi:10.7189/jogh.09.010427
12. Ponto KA, Elbaz H, Peto T, et al. Prevalence and risk factors of retinal vein occlusion: the Gutenberg health study. J Thromb Haemost. 2015;13(7):1254-1263. doi:10.1111/jth.12982
13. Frederiksen KH, Stokholm L, Frederiksen PH, et al. Cardiovascular morbidity and all-cause mortality in patients with retinal vein occlusion: a Danish nationwide cohort study. Br J Ophthalmol. 2023;107(9):1324-1330. doi:10.1136/bjophthalmol-2022-321225